Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

Nature Genetics

Volumn 17, Issue 4, 1997, Pages 439-444

  Carmeliet, Peter ^a   Moons, Lieve ^a   Lijnen, Roger ^a   Baes, Myriam ^a   Lemaǐtre, Vincent ^b   Tipping, Peter ^c   Drew, Angela ^a,c   Eeckhout, Yves ^b   Shapiro, Steve ^d   Lupu, Florea ^e   Collen, Désiré ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b International Institute of Cellular and Molecular Pathology   (Belgium)

^c MONASH MEDICAL CENTRE   (Australia)

^d BARNES JEWISH HOSPITAL   (United States)

^e THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; UROKINASE;

ANEURYSM RUPTURE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AORTA ANEURYSM; AORTA ATHEROSCLEROSIS; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GENETIC PREDISPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 16944363984     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1297-439     Document Type: Article

References (29)

1. Anidjar, S. & Kieffer, E. Pathogenesis of acquired aneurysms of the abdominal aorta. Ann. Vasc. Surg. 6, 298-305 (1992).
2. Braverman, A.C. Penetrating atherosclerotic ulcers of the aorta. Curr. Opin. Cardiol. 9, 591-597 (1994).
3. MacSweeney, S.T., Powell, J.T. & Greenhalgh, R.M. Pathogenesis of abdominal aortic aneurysm. Br. J. Surg. 81, 935-941 (1994).
4. Halloran, B.G. & Baxter, B.T. Pathogenesis of aneurysms. Semin. Vasc. Surg. 8, 85-92 (1995).
5. Patel, M.I., Hardman, D.T., Fisher, C.M. & Appleberg, M. Current views on the pathogenesis of abdominal aortic aneurysms. J. Am. Coll. Surg. 181, 371-382 (1995).
6. Libby, P. Molecular basis of the acute coronary syndromes. Circulation 91, 2844-2850 (1995).
7. Schneiderman, J. et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall: a possible mechanism for aneurysm expansion. J. Clin. Invest. 96, 639-645 (1995).
8. Newman, K.M. et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J. Vasc. Surg. 20, 814-820 (1994).
9. Halpert, I. et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. USA 93, 9748-9753 (1996).
10. Lupu, F. et al. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 15, 1444-1455 (1995).
11. Dollery, C.M., McEwan, J.R. & Henney, A.M. Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77, 863-868 (1995).
12. Galis, Z.S., Sukhova, G.K., Lark, M.W. & Libby, P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94, 2493-2503 (1994).
13. Murphy, G. Matrix metalloproteinases and their inhibitors. Acta Orthop. Scand. (Suppl. 256) 66, 55-60 (1995).
14. Collen, D. & Lijnen, H.R. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78, 3114-3124 (1991).
15. Carmeliet, P. & Collen, D. Gene manipulation and transfer of the plasminogen system and coagulation system in mice. Semin. Thromb. Hemostasis 22, 525-542 (1996).
16. Murphy, G., Atkinson, S., Ward, R., Gavrilovic, J. & Reynolds, J.J. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann. NY Acad. Sci. 667, 1-12 (1992).
17. Eeckhout, Y. & Vaes, G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Biochem. J. 166, 21-31 (1977).
18. Plump, A.S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353 (1992).
19. Carmeliet, P. et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419-424 (1994).
20. Johnston, K.W. et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg. 13, 452-458 (1991).
21. Shapiro, S.D., Kobayashi, D.K. & Ley, T.J. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 269, 23824-23829 (1993).
22. Murphy, G., Cockett, M.D., Ward, R.V. & Docherty, A.J.P. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277, 277-279 (1991).
23. Werb, Z., Banda, M.J. & Jones, P.A. Degradation of connective tissue matrices by macrophages: I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages. J. Exp. Med. 152, 1340-1357 (1980).
24. Coussens, L.M. & Werb, Z. Matrix metalloproteinases and the development of cancer. Chem. Biol. 3, 895-904 (1996).
25. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D. & Williams, R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231-240 (1987).
26. Shipley, J.M., Wesselschmidt, R.L., Kobayashi, D.K., Ley, T.J. & Shapiro, S.D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA 93, 3942-3946 (1996).
27. Carmeliet, P. et al. Urokinase-type but not tissue-type plasminogen activator mediates arterial neointima formation in mice. Circ. Res. 81, 829-839 (1997).
28. Delaissé, J. et al. (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J. Cell Sci. 106, 1071-1082 (1993).
29. Senior, R.M., Connelly, N.L., Cury, J.D., Welgus, H.G. & Campbell, E.J. Elastin degradation by human alveolar macrophages: a prominent role of metalloproteinase activity. Am. Rev. Respir. Dis. 139, 1251-1256 (1989).